These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23934529)

  • 1. [Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project].
    Fujita Y
    Nihon Yakurigaku Zasshi; 2013 Aug; 142(2):89-95. PubMed ID: 23934529
    [No Abstract]   [Full Text] [Related]  

  • 2. [Open innovation for Japanese pharmaceutical companies].
    Hoshino T
    Nihon Yakurigaku Zasshi; 2013 Oct; 142(4):184-9. PubMed ID: 24107523
    [No Abstract]   [Full Text] [Related]  

  • 3. [Open innovation: public-private partnerships in pharmaceutical R&D].
    Uchibayashi N
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):32-8. PubMed ID: 23842226
    [No Abstract]   [Full Text] [Related]  

  • 4. Why and how have drug discovery strategies in pharma changed? What are the new mindsets?
    Mignani S; Huber S; Tomás H; Rodrigues J; Majoral JP
    Drug Discov Today; 2016 Feb; 21(2):239-49. PubMed ID: 26376356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes.
    Turner MJ
    Drug Discov Today; 2015 Aug; 20(8):917-9. PubMed ID: 26100736
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
    Hoffmann T; Bishop C
    Drug Discov Today; 2010 Apr; 15(7-8):260-4. PubMed ID: 20149893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Open innovation and licensing in the pharmaceutical industry].
    Yamasaki M
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225
    [No Abstract]   [Full Text] [Related]  

  • 8. Open innovation: share or die..
    Talaga P
    Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629
    [No Abstract]   [Full Text] [Related]  

  • 9. Deconstructing the drug development process: the new face of innovation.
    Kaitin KI
    Clin Pharmacol Ther; 2010 Mar; 87(3):356-61. PubMed ID: 20130565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Open innovation for pharmaceutical industries].
    Matsumoto Y; Sakata T
    Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):199-204. PubMed ID: 23575425
    [No Abstract]   [Full Text] [Related]  

  • 11. Open innovation and intellectual property: time for a reboot?
    Judd DB
    Drug Discov Today; 2013 Oct; 18(19-20):907-9. PubMed ID: 23958455
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug discovery in the next decade: innovation needed ASAP.
    Bennani YL
    Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sprinkling the pixie dust: reflections on innovation and innovators in medicinal chemistry and drug discovery.
    Macdonald SJF; Hatley RJD
    Drug Discov Today; 2020 Mar; 25(3):599-609. PubMed ID: 31981481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affairs of the Heart: Innovation in Cardiovascular Research and Development.
    Honig P; Terzic A
    Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grants4Targets: an open innovation initiative to foster drug discovery collaborations.
    Dorsch H; Jurock AE; Schoepe S; Lessl M; Asadullah K
    Nat Rev Drug Discov; 2015 Jan; 14(1):74-6. PubMed ID: 25430867
    [No Abstract]   [Full Text] [Related]  

  • 16. Q&A: Bernard Munos.
    Bender E
    Nature; 2016 May; 533(7602):S59. PubMed ID: 27167392
    [No Abstract]   [Full Text] [Related]  

  • 17. Virtual drug discovery with the rise of Chinese CROs.
    Zhang MQ
    Drug Discov Today; 2010 Sep; 15(17-18):693-7. PubMed ID: 20685343
    [No Abstract]   [Full Text] [Related]  

  • 18. Academia and industry: allocating credit for discovery and development of new therapies.
    Flier JS
    J Clin Invest; 2019 May; 129(6):2172-2174. PubMed ID: 31107243
    [No Abstract]   [Full Text] [Related]  

  • 19. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outlook for the next 5 years in drug innovation.
    Berggren R; Møller M; Moss R; Poda P; Smietana K
    Nat Rev Drug Discov; 2012 Jun; 11(6):435-6. PubMed ID: 22653208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.